Streetbeat News

Products Services

XIACF

Xiaomi (OTC:XIACF) announced its first electric vehicle, the SU7 sedan, will be priced below $70,000. The vehicle, with two versions offering up to 800km range, surpasses Tesla's Model S in range. Official pricing will be revealed on March 28, with orders starting subsequently. Xiaomi aims to enter the top five automakers, with the CEO comparing the SU7 to Porsche Taycan and Tesla Model S. Despite new initiatives expenses, Xiaomi reported a 126.3% year-on-year profit growth for 2023.

Portfolio Pulse from Anan Ashraf

March 25, 2024 | 12:01 pm

BABA

BILI

ONLN

PGJ

XPEV

Alibaba Group Holding Ltd (NYSE:BABA) is pausing operations of its Ling Shou Tong platform to adjust its business strategy, focusing on AI and core retail and technology sectors. Despite this, LST is not shutting down or merging with another platform. Alibaba sold $360 million of Bilibili Inc (NASDAQ:BILI) shares and reduced stakes in other companies, reallocating resources towards AI. It plans to launch a new processor to counteract U.S. export controls on chip technologies. Alibaba's stock has declined over 16% in the past year, but can be accessed through ETFs like Invesco Golden Dragon China ETF (NASDAQ:PGJ) and ProShares Online Retail ETF (NYSE:ONLN).

Portfolio Pulse from Anusuya Lahiri

March 25, 2024 | 12:01 pm

AAPL

BIDU

Baidu's stock is on the rise following reports of discussions with Apple about integrating Baidu's AI technology into the iPhone 16 and other Apple products for the Chinese market.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:51 am

NICE

NICE has introduced NICE Enlighten XM, a new addition to its customer experience AI solution, Enlighten. This advancement utilizes large language models to deeply personalize customer journeys by leveraging extensive data memory.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:44 am

NVO

Actylis and Novo Nordisk Pharmatech have entered into an agreement to distribute pharmaceutical grade Benzalkonium Chloride in Germany, Spain, Portugal, the UK, and Ireland. This collaboration aims to supply the pharmaceutical and medical device markets in these regions.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:40 am

ATXS

Astria Therapeutics, Inc. (NASDAQ:ATXS) announced positive initial results from the ALPHA-STAR Phase 1b/2 trial for STAR-0215 in treating hereditary angioedema (HAE). The results showed a significant reduction in monthly attack rates and a favorable safety profile, supporting advancement to Phase 3 development with trials starting in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:40 am

MBRX

Moleculin Biotech announced a positive preliminary update on its lead program MB-106 for Acute Myeloid Leukemia treatment, highlighting a 60% CRc rate with its Annamycin and Cytarabine combination (AnnAraC) in 2nd line AML subjects. The update also noted no signs of cardiotoxicity in all 82 subjects across multiple studies and mentioned the potential for accelerated approval as it advances towards a pivotal AML study in 2024.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:36 am

AAPL

VGT

XLK

Apple Inc (AAPL) is planning to launch its Vision Pro headset in China within the year, as announced by CEO Tim Cook. The headset, priced at $3,500 in the US, marks Apple's entry into the virtual and augmented reality market. Despite a 24% drop in iPhone sales in China and a 13% decrease in revenue to $20.8 billion in the December quarter, Apple remains optimistic about the Chinese market. The stock can be accessed through ETFs like Vanguard Information Tech ETF (VGT) and SPDR Select Sector Fund - Technology (XLK). AAPL shares saw a slight decrease of 0.35% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 25, 2024 | 11:34 am

AAPL

BIDU

NVDA

PGJ

SOCL

Baidu, Inc (NASDAQ:BIDU) stock is trading higher due to a partnership with Apple Inc (NASDAQ:AAPL) to provide AI services for iPhone 16 and other products in China. This collaboration, reported by Cailian Press and the Wall Street Journal, also includes the Mac OS and iOS 18, exclusively for China. Baidu's AI capabilities, particularly its Ernie Bot, have been recognized by China's regulatory bodies, positioning it strongly in the competitive AI market. The partnership is seen as a significant endorsement of Baidu's AI advancements. Meanwhile, U.S. sanctions have affected Nvidia Corp (NASDAQ:NVDA), a key AI chip supplier to Apple. Baidu's stock has lost over 33% in value in the last 12 months but is trading higher by 1.18% at $103.39 in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 25, 2024 | 11:26 am

CMMB

Chemomab Therapeutics Ltd. (NASDAQ:CMMB) has been granted a new European patent for CM-101, its monoclonal antibody in Phase 2 clinical development for treating primary sclerosing cholangitis. The patent strengthens Chemomab's intellectual property for CM-101, which targets CCL24, a key player in fibrosis and inflammation. The global Phase 2 SPRING trial for CM-101 has completed patient enrollment, with results expected by mid-2024.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:09 am